SEC Form 4 · accession 0001562180-18-004643
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luke M Beshar
Director
Period of report
Nov 19, 2018
Accepted (ET)
Nov 21, 2018 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 19, 2018 | M | 2,604 | $49.45 | A | 2,604 | D | |
| Common Stock | Nov 19, 2018 | M | 6,250 | $18.85 | A | 8,854 | D | |
| Common Stock | Nov 19, 2018 | M | 3,262 | $12.74 | A | 12,116 | D | |
| Common StockF2 | Nov 19, 2018 | S | 10,916 | $60.26 | D | 1,200 | D | |
| Common StockF3 | Nov 19, 2018 | S | 600 | $62.81 | D | 600 | D | |
| Common StockF4 | Nov 19, 2018 | S | 600 | $63.53 | D | 0 | D | |
| Common Stock | Nov 20, 2018 | M | 4,688 | $22.00 | A | 4,688 | D | |
| Common Stock | Nov 20, 2018 | M | 2,988 | $12.74 | A | 7,676 | D | |
| Common Stock | Nov 20, 2018 | M | 13,500 | $3.76 | A | 21,176 | D | |
| Common StockF5 | Nov 20, 2018 | S | 21,176 | $60.38 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $49.45 | Nov 19, 2018 | M | 2,604 | D | — | May 25, 2028 | Common Stock | 2,604 | 9,896 | D |
| Stock Option (Right to Buy)F7 | $18.85 | Nov 19, 2018 | M | 6,250 | D | — | May 24, 2027 | Common Stock | 6,250 | 6,250 | D |
| Stock Option (Right to Buy)F8 | $12.74 | Nov 19, 2018 | M | 3,262 | D | — | Jun 1, 2026 | Common Stock | 3,262 | 9,238 | D |
| Stock Option (Right to Buy)F9 | $22.00 | Nov 20, 2018 | M | 4,688 | D | — | Sep 16, 2025 | Common Stock | 4,688 | 4,687 | D |
| Stock Option (Right to Buy)F8 | $12.74 | Nov 20, 2018 | M | 2,988 | D | — | Jun 1, 2026 | Common Stock | 2,988 | 6,250 | D |
| Stock Option (Right to Buy)F10 | $3.76 | Nov 20, 2018 | M | 13,500 | D | — | May 18, 2025 | Common Stock | 13,500 | 66,500 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F10The previously granted option, representing a right to purchase a total of 80,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter.
- F2This transaction was executed in multiple trades at prices ranging from $60.00 to $60.685. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $62.06 to $63.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $63.34 to $64.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $60.00 to $60.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vests in 12 equal monthly installments following May 25, 2018.
- F7The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following May 24, 2017.
- F8The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016.
- F9The previously granted option, representing a right to purchase a total of 9,375 shares, became exercisable as follows: the option vested in nine equal monthly installments following September 16, 2015.